Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
95% Confidence Interval
44%
Age at Menarche
9%
All-cause Mortality
10%
Body Mass Index
16%
BRCA2
21%
Breast Cancer
87%
Breast Cancer Association Consortium
41%
Breast Cancer Cases
13%
Breast Cancer Risk
100%
Breast Cancer Susceptibility
31%
C-reactive Protein
14%
Cancer Risk
27%
Checkpoint Kinase 2 (CHEK2)
17%
Copenhagen
12%
ER+ Breast Cancer
19%
Estrogen Receptor-positive
11%
European Ancestry
31%
Fine Mapping
18%
General Population Studies
15%
Genetic Variants
14%
Genome-wide Association Study
38%
Genotype
20%
Hazard Ratio
16%
High Risk
15%
Lung Cancer
44%
Lung Cancer Risk
31%
Mendelian Randomization
11%
Mendelian Randomization Analysis
11%
Mendelian Randomization Study
23%
Meta-analysis
24%
Methylation
10%
Non-carriers
11%
Odds Ratio
31%
Pancreatic Cancer
10%
Polygenic Risk Score
18%
Prospective Cohort Study
11%
Prostate Cancer
16%
Prostate Cancer Risk
12%
Psoriasis
9%
Risk Factors
10%
Risk Loci
18%
Risk Variant
11%
Single nucleotide Polymorphism
32%
SNP
24%
Susceptibility Loci
44%
Susceptibility Variants
10%
Telomere Length
17%
Tumor
10%
Tumor Subtype
9%
YKL-40
22%
Biochemistry, Genetics and Molecular Biology
Allele
38%
Association Study
7%
Binding Site
6%
Blood Plasma
11%
Body Mass
15%
BRCA1
30%
BRCA2
21%
C-Reactive Protein
6%
Cancer Specific Survival
8%
Cancer Survival
10%
Case-Control Study
8%
CHEK2
19%
CHRNA3
6%
Cohort Study
10%
Common Variant
12%
Enhancer Region
13%
Estrogen Receptor
42%
Expression Quantitative Trait Loci
9%
Gene Expression
6%
Gene-Environment Interaction
9%
Genetic Divergence
26%
Genetic Risk
7%
Genetic Susceptibility
8%
Genetic Variation
6%
Genetics
40%
Genome Wide Association Study
11%
Genome-Wide Association Study
42%
Genomics
9%
Genotyping
34%
Germ Cell
22%
Germline
22%
Homozygote
13%
Hormone Receptor
9%
Leukocyte
8%
Maturity Onset Diabetes of the Young
6%
Menarche
9%
Mendelian Randomization
29%
Methylation
9%
Missense
8%
Polygenic Score
18%
Population Research
10%
Progesterone Receptor
6%
Promoter Region
6%
Prospective Cohort Study
6%
Prospective Study
6%
Single Nucleotide Polymorphism
32%
Single-Nucleotide Polymorphism
35%
Susceptibility Gene
10%
Telomere
12%
Telomere Length
18%
